The detection of CTCs as defined by the EpCAM+/CK+/DAPI+/CD45− expression pattern has been observed in the blood of metastatic cancer patients, including mBC, and their relevance affecting metastatic competence has been established [16,21,45,46,47,48]. Here, PTPRC is linked to metastatic malignant neoplasm.